The weakened general economic development and government interventions are slowing down market growth in some of Tamro’s markets. However, for the remaining financial year, Tamro expects the results to equal or exceed last year’s thanks to operational improvements and cost focus.

Tamro is following how the Swedish government is handling the deregulation process. It remains to be seen whether the new system will encourage market dynamics and international players to create a functioning pharmacy market, based on secure and efficient distribution as well as  high customer benefits. Depending on the Swedish government’s model for a deregulated pharmacy market Tamro may decide to enter the retail market. The deregulation in Sweden will have a major effect on Tamro’s performance, but its financial impact will not be substantial before the financial year 2009/10 and thereafter.